Zobrazeno 1 - 10
of 850
pro vyhledávání: '"S. Wirtz"'
Publikováno v:
Cuadernos de Investigación Geográfica, Vol 43, Iss 1, Pp 171-187 (2017)
Las unidades geomorfológicas están relacionadas con ciertos procesos y con la historia de su formación. Además, se definen por sus formas y materiales. En este estudio se investigan los procesos de erosión en diferentes unidades de relieve. Simu
Externí odkaz:
https://doaj.org/article/f096bc3e5c254bd9b154629b10b711ac
Publikováno v:
Cuadernos de Investigación Geográfica, Vol 41, Iss 1, Pp 63-85 (2015)
For a long time, studies concerning erosion caused by concentrated overland flow mainly dealt with the erosion and the transport of fine material. More recent studies have shown that rock fragments reduce the intensity of soil erosion processes on th
Externí odkaz:
https://doaj.org/article/fea6de0845554ec5b3ac43755b989fd5
Autor:
Nimira Alimohamed, Simrun Grewal, Heidi S. Wirtz, Zsolt Hepp, Stephanie Sauvageau, Devon J. Boyne, Darren R. Brenner, Winson Y. Cheung, Tamer N. Jarada
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7587-7597 (2022)
Despite a high disease burden, real-world data on treatment patterns in patients with unresectable locally advanced or metastatic urothelial carcinoma (la/mUC) in Canada are limited. This retrospective, longitudinal cohort study describes treatment p
Externí odkaz:
https://doaj.org/article/58c125ba29bf4bb786002ff86ce20d93
Autor:
Kaleigh L. Evans, Heidi S. Wirtz, Jia Li, Ruicong She, Juan Maya, Hongsheng Gui, Andrew Hamer, Christophe Depre, David E. Lanfear
Publikováno v:
Human Genomics, Vol 13, Iss 1, Pp 1-11 (2019)
Abstract Background Elevated resting heart rate (HR) is a risk factor and therapeutic target in patients with heart failure (HF) and reduced ejection fraction (HFrEF). Previous studies indicate a genetic contribution to HR in population samples but t
Externí odkaz:
https://doaj.org/article/5eda19951fbc4b38a90eab63ebc603d3
Autor:
Colleen A McHorney, Sonal G Mansukhani, Milena Anatchkova, Natalie Taylor, Heidi S Wirtz, Siddique Abbasi, Lynwood Battle, Nihar R Desai, Gary Globe
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248240 (2021)
BackgroundHeart failure is rising in prevalence but relatively little is known about the experiences and journey of patients and their caregivers. The goal of this paper is to present the symptom and symptom impact experiences of patients with heart
Externí odkaz:
https://doaj.org/article/9d0d4f9ae4c64a25b18d6c950c23f908
Autor:
Joseph W. Rossano, Paul F. Kantor, Robert E. Shaddy, Ling Shi, James D. Wilkinson, John L. Jefferies, Jason D. Czachor, Hiedy Razoky, Heidi S. Wirtz, Christophe Depre, Steven E. Lipshultz
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 15 (2020)
Background In adults with heart failure, elevated heart rate is associated with lower survival. We determined whether an elevated heart rate was associated with an increased risk of death or heart transplant in children with dilated cardiomyopathy. M
Externí odkaz:
https://doaj.org/article/8d374e813d844b36a913e5fe9dc6eab8
Autor:
Heidi S. Wirtz, Richard Sheer, Narimon Honarpour, Adrianne W. Casebeer, Jeff D. Simmons, Christopher E. Kurtz, Margaret K. Pasquale, Gary Globe
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 16 (2020)
Background Patients hospitalized with heart failure (HF) with reduced ejection fraction have high risk of rehospitalization or death. Despite guideline recommendations based on high‐quality evidence, a substantial proportion of patients with HF wit
Externí odkaz:
https://doaj.org/article/27a624325c3641bd8bdd24f1b97943e9
Autor:
Jennifer A. Rymer, Katherine E. Mues, Keri L. Monda, Emily W. Bratton, Heidi S. Wirtz, Ted Okerson, Robert A. Overman, M. Alan Brookhart, Paul Muntner, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 9 (2020)
Background Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) are used to reduce low‐density lipoprotein (LDL) cholesterol. PCSK9i use after initiation, as well as persistence with or alterations to other LDL‐lowering therapy after
Externí odkaz:
https://doaj.org/article/aada6edd7f1a471f9a160c2a92af5b56
Autor:
B Schmitz, S Wirtz, M Sestayo-Fernandez, H Schaefer, E R Douma, M Alonso, V Gonzalez-Salvado, M Habibovic, W J Kop, C Pena-Gil, F C Mooren
Publikováno v:
European Journal of Preventive Cardiology. 30
Funding Acknowledgements Type of funding sources: Public grant(s) – EU funding. Main funding source(s): H2020. Background eHealth solutions may be used for personalized care and to provide assistance for disease control to CAD patients over the com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ca61bc6db3eb2f2ba88634078e4637e
https://doi.org/10.1093/eurjpc/zwad125.088
https://doi.org/10.1093/eurjpc/zwad125.088
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.